CoMotion DubPitch is a twice-yearly event which brings together startups and early-stage innovations from the UW with investors and venture capitalists. Leaders from the companies and projects deliver ten-minute pitches, offering investment opportunities ranging from pre-seed to Series A. CoMotion mentors provide support in advance of the event by offering guidance and recommendations to the teams as they hone their presentations.
Spring 2022
Seven teams gathered in person for the Spring ‘22 CoMotion DubPitch event to pitch their companies to an audience of investors and venture capitalists. All the teams are based on UW research or are from CoMotion Labs, our multi-industry incubator. The event featured startups from a broad range of sectors including life sciences, medical devices, IT and software, hardware, and cleantech.
- Jo He
AeroSpec is an air quality monitoring platform with a special emphasis on data analytics. We focus on using our air quality monitor, mobile app, and online dashboard to make air quality information more accessible and actionable to everyone.
- Wei Sun
At AIWaysion, we provide Smart Mobility Solutions using Artificial Intelligence (AI) and edge computing technologies for safer and more efficient transportation.
Website
www.aiwaysion.com
- Barbara Barclay
Somalytics’ nanotech-infused paper capacitive sensor solves development challenges in eye tracking, wearables, and human machine interaction, and due to its miniaturization, speed and power advances, will open up entirely new application areas.
Website
www.somalytics.com
- Branden Doyle
Violett is transforming air disinfection technology for a post-pandemic world.
Website
www.violett.com
- Amy Swanson
Ultropia is developing an all-in-one washer and dryer to help people with limited infrastructure gain access to laundry machines by providing a resource, energy, and time saving product made possible with ultrasonic technology.
Website
www.ultropia.us
- Jeff Gross
The transformation of scientific discovery to a platform product to prophylactically mitigate heterotopic ossification.
- Benjamin Freedman
Plurexa’s goal is to make therapeutics innovation faster, cheaper, and easier by leveraging the power of human miniorgans: three-dimensional structures that capture key features of human organs in the convenient form of a petri dish.
Website
www.minikidney.com